Follicular lymphomas and their transformation: Past and current research

References

• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116:3724.
   PubMed Web of Science ®Google Scholar
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The non-Hodgkin’s lymphoma classification project. Blood. 1997;89:3909.
   PubMed Web of Science ®Google Scholar
• Lorsbach RB, Shay-Seymore D, Moore J, et al. Clinicopathologic analysis of follicular lymphoma occurring in children. Blood. 2002;99:1959.
   PubMed Web of Science ®Google Scholar
• Louissaint A Jr, Schafemak K, Geyer J, et al. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathways mutations.
   Google Scholar
• Takata K, Tanino M, Ennishi D. Doudenal follicular lymphoma: comprehensive gene expression analysis whit insights into pathogenesis. Cancer Sci. 2014;105:608–615.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hernandez AM, Shibata D, et al. BCL2 translocation frequency rises with age in humans. ProcNatlAcadSciUSA. 1994;91:8910–8914.
   PubMed Web of Science ®Google Scholar
• Bende RJ, Smit LA, Van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia. 2007;21:18.
   PubMed Web of Science ®Google Scholar
• Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;311:1471.
   PubMed Web of Science ®Google Scholar
• Oviatt KL, Couser JB, Collins RD, et al. Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer. 1984;53:1109–1114.
   PubMed Web of Science ®Google Scholar
• Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. Cancer Treat Rep. 1981;65:413–418.
   PubMedGoogle Scholar
• Qazi R, Aisenberg AC, Long JC. The natural history of nodular lymphoma. Cancer. 1976;37:1923–1927.
   PubMed Web of Science ®Google Scholar
• Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol. 2008;26:5165–5169.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva, Switzerland: World Health Organization; 2008.
   Google Scholar
• De Jong D, Voetdijk BM, Beverstock GC, et al. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med. 1988;318:1373–1378.
   PubMed Web of Science ®Google Scholar
• Gauwerky CE, Haluska FG, Tsujimoto Y, et al. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acadsciusa. 1988;85:8548–8552.
   PubMed Web of Science ®Google Scholar
• Gall EA, Mallory TB. Malignant lymphoma: a clinico-pathologic survey of 618 cases. Am J Pathol. 1942;18:381–429.
   PubMedGoogle Scholar
• Lossos IS. Higher-grade transformation of follicular lymphoma-a continuous enigma. Leukemia. 2005;19:1331–1333.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Alizadeh AA, Diehn M, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-MYC and its regulated genes. Proc Natl Acadsci USA. 2002;99:8886–8891.
   PubMed Web of Science ®Google Scholar
• Do B, Lossos IS, Thorstenson Y, et al. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma. 2003;44:1317–1323.
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS, Gascoyne RD, Lim MS, et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood. 1998;91:4677–4685.
   PubMed Web of Science ®Google Scholar
• Glas AM, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clinoncol. 2007;25:290–298.
   Web of Science ®Google Scholar
• Canioni D, Salles G, Mounier N, et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clinoncol. 2008;26:440–446.
   PubMed Web of Science ®Google Scholar
• De Jong D. Molecular patogénesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clinoncol. 2005;23:6358–6363.
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood. 2007;110:4455–4463.
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Wang S, Mauer MJ, et al. Prognostic significance of host gene polymorphisms in follicular lymphoma. Blood. 2007;109:5439–5446.
   PubMed Web of Science ®Google Scholar
• Jong D, Boer JP. Predicting transformation in follicular lymphoma. Leuk Lymphoma. 2009;50:1406–1411.
   PubMed Web of Science ®Google Scholar
• Gine E, Montoto S, Bosch F, et al. The follicular lymphoma international prognostic index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol. 2006;17:1539–1545.
   PubMed Web of Science ®Google Scholar
• Al-Mansour M, Connors JM, Gascoyne RT, et al. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin’s lymphoma. J Clin Oncol. 2010;28:793–799.
   PubMed Web of Science ®Google Scholar
• Yuen AR, Kamel OW, Halpern J, et al. Long term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol. 1995;13:1726–1733.
   PubMed Web of Science ®Google Scholar
• Cullen MH, Lister TA, Brearley RI, et al. Histological transformation of non-Hodgkin’s lymphoma: a prospective study. Cancer. 1979;44:645–651.
   PubMed Web of Science ®Google Scholar
• Risdall R, Hoppe RT, Warnke R. Non-Hodgkin’s lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer. 1979;44:529–542.
   PubMed Web of Science ®Google Scholar
• Garvin AJ, Simon RM, Osborne CK, et al. An autopsy study of histologic progression in non-Hodgkin’s lymphomas.192 cases from the National Cancer Institute. Cancer. 1983;52:393–398.
   PubMed Web of Science ®Google Scholar
• Ostrow SS, Diggs CH, Sutherlan JC, et al. Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival. Cancer Treat Rep. 1981;65:929–933.
   PubMedGoogle Scholar
• Hubbard SM, Chabner BA, De Vita VT. Histologic progression in non-Hodgkin´s lymphoma. Blood. 1982;59:258–264.
   PubMed Web of Science ®Google Scholar
• Acker B, Hoppe RT, Colby TV, et al. Histologic conversion in the non-Hodgkin’s Lymphoma. J Clinoncol. 1983;1:11–16.
   PubMed Web of Science ®Google Scholar
• Gallagher CJ, Gregory WM, Jones AE, et al. Follicular lymphoma: prognostic factors for response and survival. J Clinoncol. 1986;4:1470–1480.
   PubMed Web of Science ®Google Scholar
• Ersboll J, Schultz HB, Pedersen-Bjergaard J, et al. Follicular low-grade non-Hodgkin’s lymphoma: long-term outcome with or without tumor progression. Eur J Haematol. 1989;42(1):55–63.
   Google Scholar
• Bastion Y, Sebban C, Berger F, et al. Incidence, predictive factors and outcome of lymphoma transformation in follicular lymphoma patients. J Clinoncol. 1997;15:1587–1594.
   PubMed Web of Science ®Google Scholar
• Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clinoncol. 2007;25:2426–2433.
   PubMed Web of Science ®Google Scholar
• Conconi A, Ponzio C, Lobetti-Bodoni C, et al. Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol. 2012;157:188–196.
   PubMed Web of Science ®Google Scholar
• Link BK, Mauer M, Nowakowski G, et al. Rates and outcomes of follicular lymphoma transformation in the inmunochemotherapy era: a report from the university of iowa/mayo clinc specialized program of research excellence molecular epidemiology resource. J Clin Oncol. 2013;31:3272–3278.
   PubMed Web of Science ®Google Scholar
• Bains P, Al Tourah A, Campbell BA, et al. Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. Ann Oncol. 2013;24:428–432.
   PubMed Web of Science ®Google Scholar
• Wagner-Johnston N, Link B, Byrtek M, et al. Outcomes of transformed follicular lymphoma in the modern era: a report from the national lymphocare study (NLCS). Blood. 2015;126:851–857.
   PubMed Web of Science ®Google Scholar
• Sarkozy C, Trneny M, Xerri L, et al. Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first line immunochemotherapy in the PRIMA trial. J Clin Oncol. 2016;34:2575–2582.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res Clinhaematol. 2011;24:135–146.
   PubMed Web of Science ®Google Scholar
• Haralambieva E, Boerma EJ, Van Imhoff GW, et al. Clinical immunophenotypic and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surgpathol. 2005;29:1652–1660.
   Google Scholar
• Ning Y, Foss A, Kimball AS, et al. Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia. Mol Cytogent. 2013;6:34–40.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang L, Wang Y, et al. Doble-hit and triple hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. Int J Clin Exp Pathol. 2013;6:788–794.
   PubMed Web of Science ®Google Scholar
• Pedersen MO, Gang AO, Poulsen TS, et al. Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma- a single centre’s experience. Eur J Haematol. 2012;89:63–71.
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Talmant P, Touzeau C, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-myc rearrangement. Haematologica. 2007;92:1335–1342.
   PubMed Web of Science ®Google Scholar
• Smeltzer J, Jones J, Ziesmer S, et al. Patterns of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin Cancer Res. 2014;20:2862–2872.
   PubMed Web of Science ®Google Scholar
• Ruminy P, Jardin F, Picquenor JM, et al. S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells. Blood. 2008;112:1951–1959.
   PubMed Web of Science ®Google Scholar
• Carlotti E, Wrench D, Matthews J, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood. 2009;113:3553–3557.
   PubMed Web of Science ®Google Scholar
• Eide MB, Liestol K, Lingjaerde OC, et al. Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. Blood. 2010;116:1489–1497.
   PubMed Web of Science ®Google Scholar
• Okosun J, Bodor C, Wang J, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature. 2014;46:176–181.
   Web of Science ®Google Scholar
• Martínez-Climent JA, Alizadeh A, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 2003;101:3109–3117.
   PubMed Web of Science ®Google Scholar
• Davies AJ, Lee A, Taylor C, et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia. 2005;19:1459–1465.
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS, Gascoyne RD, Lim M, et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood. 1998;91:4677–4685.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol. 2003;13:191–202.
   PubMed Web of Science ®Google Scholar
• Sander CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993;82:1994–2004.
   PubMed Web of Science ®Google Scholar
• Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 2000;95:651–659.
   PubMed Web of Science ®Google Scholar
• Davies AJ, Rosenwald G, Lee A, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol. 2006;136:286–293.
   Web of Science ®Google Scholar
• Hans SP, Weisenburger DD, Greiner TC, et al. Conformation of molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.
   PubMed Web of Science ®Google Scholar
• Kridel R, Mottok A, Farinha P, et al. Cell of origin of transformed follicular lymphoma. Blood. 2015;126:2118–2127.
   PubMed Web of Science ®Google Scholar
• Brodtkorb M, Lingjaerde C, Huse K, et al. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood. 2014;123(7):1051–1054.
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS, Jenson SD, Abbott RT, et al. Involvement of multiple signalling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as target for therapy. Proc Natl Acadsci USA. 2003;100:7259–7264.
   PubMed Web of Science ®Google Scholar
• Blaker Y, Spetalen S, Brodtkorb M, et al. The tumour microenvironment influences survival and time to transformation in folicular lymphoma in the rituximab era. Br J Haematol. 2016. [Epub ahead of print]. DOI:10.1111/bjh.14201
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of Follicular lymphoma transformation. Cell. 2014;6:130–140.
   Web of Science ®Google Scholar
• Baus D, Nonnenmacher F, Jankowski S, et al. STAT6 and STAT1 are essencial antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line. Leukemia. 2009;23:1885–1893.
   PubMed Web of Science ®Google Scholar
• Kridel R, Chan FC, Mottok A, et al. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLOS One. 2016;13:e1002197.
   Google Scholar